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ABSTRACT Pseudomonas aeruginosa is a common cause of infection in the lungs of patients with cystic ﬁbrosis (CF). In addition,
bioﬁlmformationandantibioticresistanceof Pseudomonasaremajorproblemsthatcancomplicateantibiotictherapy.Weeval-
uatedtheefﬁcacyofusingbacteriophagestokillthepathogeninbothbioﬁlmsandinthemurinelung.Weisolatedandcharac-
terizedtwophagesfromalocalwastewatertreatmentplant,amyovirus(NH-4)andapodovirus(MR299-2).Bothphages
were active against clinical isolates of P. aeruginosa. Together, the two phages killed all 9 clinical isolate strains tested, including
both mucoid and nonmucoid strains. An equal mixture of the two phages was effective in killing P. aeruginosa NH57388A (mu-
coid) and P. aeruginosa MR299 (nonmucoid) strains when growing as a bioﬁlm on a cystic ﬁbrosis bronchial epithelial
CFBE41o-cellline.Phagetitersincreasedalmost100-foldovera24-hperiod,conﬁrmingreplicationofthephage.Furthermore,
the phage mix was also effective in killing the pathogen in murine lungs containing 1  107 to 2  107 P. aeruginosa. Pseudomo-
naswaseffectivelycleared(reducedbyamagnitudeofatleast3to4logunits)frommurinelungsin6h.Ourstudydemonstrates
theefﬁcacyofthesetwophagesinkillingclinical Pseudomonasisolatesinthemurinelungorasabioﬁlmonapulmonarycell
lineandsupportsthegrowinginterestinusingphagetherapyforthecontrolandtreatmentofmultidrug-resistant Pseudomonas
lunginfectionsinCFpatients.
IMPORTANCE Giventheriseinantibioticresistance,nonantibiotictherapiesarerequiredforthetreatmentofinfection.Thisis
particularlytrueforthetreatmentof Pseudomonasinfectioninpatientswithcysticﬁbrosis.Wehaveidentiﬁedtwobacterial
viruses(bacteriophages)thatcankill Pseudomonasgrowingonhumanlungcellsandinananimalmodeloflunginfection.The
useofbacteriophagesisparticularlyappropriatebecausethekillingagentcanreplicateonthetargetcell,generatingfreshcopies
ofthebacteriophage.Thus,inthepresenceofatarget,thekillingagentmultiplies.Byusingtwobacteriophageswecanreduce
theriskofresistantcoloniesdevelopingatthesiteofinfection.Bacteriophagetherapyisanexcitingﬁeld,andthisstudyrepre-
sentsanimportantdemonstrationofefﬁcacyinvalidatedinfectionmodels.
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C
ystic ﬁbrosis (CF) is an inherited genetic disorder that chron-
ically affects the lungs and digestive system (pancreas and in-
testine) of children and adults worldwide. CF also affects the mu-
cus and glands of the liver, sinuses, and sex organs causing
progressive disability due to multiorgan system failure. CF results
from mutations in the transmembrane conductance regulator
gene (1–3). The defective enzyme leads to the production of un-
usuallythickandstickymucusandhighlevelsofchloridecontain-
ing secretions into ducts and body cavities. These secretions clog
the lungs, leading to life-threatening infections (4, 5).
The lungs of CF patients are often colonized at infancy or in
early childhood with Pseudomonas aeruginosa that may damage
the epithelial surface, resulting in altered airway physiology and
impairment of mucocillary clearance. This chronic infection is
one of the main causes of lung function decline and mortality in
CFpatients(6,7).Indeed,80to95%ofpatientswithCFsuccumb
torespiratoryfailurebroughtaboutbychronicbacterialinfection
andconcomitantairwayinﬂammation(7).P.aeruginosaispartic-
ularly persistent in the lungs due to its aerobic nature and its
ability to form bioﬁlms in the lungs of CF patients. Another sig-
niﬁcant factor is the inherent resistance of P. aeruginosa to many
antibiotics due to membrane impermeability (8–12). Other ac-
quired mechanisms of resistance include production of
-lactamases and carbapenemases (13) and multidrug efﬂux
pumps (14). It has also been noted that the most prevalent and
severechroniclunginfectionsinCFpatientsarecausedbymucoid
P. aeruginosa strains (4, 11, 15).
Reports have shown that organisms in bioﬁlms are able to tol-
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bacteria(16,17),andthiscanmeanthattheantibioticconcentra-
tion needed to eradicate a bioﬁlm is higher than the peak serum
concentration (18), rendering it ineffective. The continued emer-
genceandreemergenceofbioﬁlm-formingPseudomonasresistant
to one or more antibiotics pose a continuous challenge in the
treatment of lung infections in CF patients. As a result, there is a
needforalternative,nonantibioticapproachessuchasphagether-
apy (19, 20). Although phage therapy has been practiced in East-
ern European countries for decades, it has been neglected by the
Western world for many years. However, there is now a growing
interest in the use of phage therapy for the control and treatment
of multidrug-resistant bacterial infections in general, and for
Pseudomonas lung infections in CF patients in particular. Studies
on phage efﬁcacy in clearing of bioﬁlms formed on abiotic sur-
faces (catheters and microtiter plates) by P. aeruginosa conﬁrmed
that phage can reduce the bacterial load in these bioﬁlms by 50 to
99% (21, 22). A recent in vitro study showed that Pseudomonas
phage PT-6 was able to reduce the viscosity of alginate polymers
extractedfromP.aeruginosabyalmost65%,amechanismusedby
phages to attack the exopolysaccharide matrix of mucoid Pseu-
domonas to gain access to the host cell (23). Recent reports show
the promising role phage therapy could play in the treatment of
acute lung infections in an in vivo murine lung model with
P. aeruginosa (24, 25) and Burkholderia cenocepacia (26). The ef-
fectiveness of phage therapy in rescuing larvae (an invertebrate
infectionmodel)infectedwithBurkholderiacepaciacomplexfrom
death was reported by Seed and Dennis (27).
Currently, there is little information concerning the effect of
bacteriophageonbioﬁlmsgrowingonalungtissuemodel.Inthis
report, we describe how a mixture of two newly isolated phages
can kill and clear lux-tagged Pseudomonas from the lungs of in-
fected mice and in bioﬁlms growing on the surface of a cystic
ﬁbrosisbronchialepithelial(CFBE41o-)monolayer.Inthisstudy,
we used bioluminescence imaging—a powerful tool for studying
bacterial infections in small-animal models, since it allows accu-
rate real-time in vivo temporal and spatial tracking of tagged bac-
teria in living animals (25, 28). Monitoring the light emitted by
tagged Pseudomonas cells in vivo was a valuable tool in verifying
the effectiveness of the phage mix to kill the pathogen. Pseudomo-
nas cell numbers were reduced by a magnitude of 3 to 4 log units
whenthephagemixwastestedinbothinvivoandinvitrosystems.
RESULTS
Isolation of phage from a sewage treatment plant. The overall
aimofthisstudywastoassessthepotentialofbacteriophagether-
apytotreatPseudomonaslunginfections.Weinitiallyisolatedtwo
phages, NH-4 and MR299-2, from sewage obtained from a
water treatment plant. Both phages were demonstrated to be vir-
ulenttoP.aeruginosa.Scanningelectronmicroscopyrevealedthat
phageMR299-2virionshaveisometriccapsidsof40to60nmin
diameter and very short tails measuring 10 to 20 nm (Fig. 1A).
Morphologically, phage MR299-2 shows similarity to Pseu-
domonasPap3(29),apodovirusthathasanisometriccapsidand
short tail. We have assigned MR299-2 to type species coliphage
T7 and to the family Podoviridae (Report of the International
CommitteeonTaxonomyofViruses[30,31]).PhageNH-4pos-
sessed an isometric capsid of 50 to 60 nm in diameter and a con-
tractile nonﬂexible tail with cross striations (noncontracted tail
lengthof150nmandcontractedtaillengthof85nm;taildiameter
of20nmwhencontracted).Inaddition,aputativeDNAinjecting
structure of 70 nm in length (narrower than the contracted tail
sheath) and tail ﬁbers were observed (Fig. 1B). Morphologically,
NH-4 shows similarity to PB1, LBL3, and SN that are clas-
siﬁedintotheT4morphologicalgroupoftheMyoviridae(32).On
the basis of structural characteristics obtained from the micro-
scopic analysis, we assign NH-4 as a member of the Myoviridae
familyaccordingtotheInternationalCommitteeonTaxonomyof
Viruses (30, 31).
AnequalratioofNH-4andMR299-2wasusedinallexper-
imentstoassesstheirabilitytokillPseudomonas.Thehostrangeof
NH-4 and MR299-2 was determined by exposing different CF
Pseudomonas isolates to each individual phage using a plaque as-
say.OfthetenPseudomonasisolatestested,eightweresensitiveto
both phages, while all were sensitive to at least one phage (Ta-
ble 1). When the 299-2 and NH-4 phages were added to Pseu-
domonas in LB broth either separately or in combination, the in-
dividual phage resulted in reduction of 3 to 4 log units while the
combination of the two resulted in a reduction of about 4.5 log
units (see Table S1 in the supplemental material).
Phage genome overview. Before phage can be used in human
therapy,itisimportanttoassessanypotentialriskassociatedwith
the phage genomes such as the presence of genetic determinants
for toxins or other virulence factors or for the capability to inte-
grate into the host genome. The complete sequences of phages
299-2 and NH-4 were determined using 454 pyrosequencing.
Phage 299-2 consists of a double-stranded DNA (dsDNA) mol-
ecule of 44,789 bp with a GC content of 52%, signiﬁcantly lower
FIG 1 Scanning electron microscopy images of phage 229-2, a podophage
(A) and phage NH-4, a myophage (B), stained with 0.2% phosphotungstic
acid.Thearrowspointtotheshorttail(10to20nmlong)ofthepodophagein
panel A and to the contracted tail sheath of the myovirus in panel B.
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content of this phage are similar to the closely related Pseudomo-
nas phage PaP3 (29). A total of 68 open reading frames (ORFs)
are predicted, 21 of which have a leftward orientation and 47 of
which are transcribed to the right (Fig. 2). Three tRNA genes
(tRNAAsn, tRNAAsp, and tRNAPro) were also identiﬁed in phage
299-2, clustered at the 5’ end of the genome. While 299-2 is a
lytic phage, comparative genomic analysis revealed that its closest
homolog is the temperate Pseudomonas phage, PaP3 (29), iso-
lated from hospital sewage. Interestingly, a recent study calls into
question the temperate nature of PaP3, since no site-speciﬁc
recombinaseisencodedup-ordownstreamofthePaP3attPsite,
and immunity or reactivation of the integrated PaP3 DNA was
not demonstrated (33). Of the 68 predicted protein products of
299-2, 56 display the highest amino acid identity to proteins
from PaP3 (see Table S3 in the supplemental material). Among
theseareproteinsinvolvedinparticleformation(ORF03,ORF04,
ORF06,andORF07),genomereplication(ORF29,ORF33/40,en-
coding DNA polymerase I subunits and ORF41, a putative pri-
mase/helicase), a putative lysozyme-like endolysin (ORF02) and
47 proteins of hypothetical function. A conserved genomic orga-
nization is also evident on comparing 299-2 to PaP3. The re-
maining 12 ORFs show signiﬁcant identity to proteins from the
lyticPseudomonasphageLUZ24(33).AccordingtoCeyssensetal.,
PaP3andLUZ24representanewgenuswithinthePodoviridae
family (33). Considering the close relationship between 299-2
and PaP3 and LUZ24, it is likely that 299-2 also belongs to
this genus.
Phage NH-4 is a member of the widespread and conserved
PB1-likeviruses,withagenomeof66,116bpandaGCcontentof
55.5%, also signiﬁcantly lower than that of its host. A total of 94
ORFswereidentiﬁedinthesequence;thepredictedproteinprod-
ucts of 56 of these ORFs have the highest amino acid identity to
LMA2 (ST4), isolated from a river in Maastricht, Holland, in
2007(32).OtherNH-4proteinsshowsigniﬁcantidentitytopre-
dictedproteinsfromPB1-likevirusessuchas14-1,SN,LBL3,
TABLE 1 Strains and plasmids used in this study
Strain or plasmid Descriptiona
Sourceb
or reference
Sensitivityc of strain
to the following phage:
NH-4 MR299-2
Pseudomonas aeruginosa strains
MR299 Human CF sputum isolate CUH  
MR299::p16Slux lux-tagged MR299 This study  
NH57388A Stable mucoid CF mouse sputum isolate 20  
NH57388A::p16Slux lux-tagged NH57388A This study  
MR300 Human CF sputum isolate CUH  
MR325 Human CF sputum isolate CUH 
MR326 Human CF sputum isolate CUH  
MR327 Human CF sputum isolate CUH  
MR330 Human CF sputum isolate CUH  
MR331 Human CF sputum isolate CUH  
CH001 Human CF sputum isolate AH  
POA1 UCC culture collection UCC  
Plasmid p16Slux lux-tagged plasmid vector 19
a UCC, University College Cork.
b CUH, Cork University Hospital (Cork, Ireland); AH, Alimentary Health Ltd. (Cork, Ireland).
c Symbols: , very strong lysis; , strong lysis; , moderate lysis; , no lysis.
FIG2 Genome organization of phage MR299-2 (top) and NH-4 (bottom). The predicted open reading frames are indicated by the thick arrows, which are
shaded to show the level of protein identity to the corresponding regions of the closest P. aeruginosa (phage PaP3 for MR299-2) or phage LMA2 (for NH-4).
Phage for Pseudomonas aeruginosa
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viruses, the genes in NH-4 are arranged in a compact manner
and appear to be organized into at least 7 transcriptional blocks,
alternating on both strands (Fig. 2). Based primarily on sequence
similarity to ORFs in the genomes of phages LMA2 and JG024,
genomic regions encoding phage particle formation (ORF19 to
-47) and phage DNA replication (ORF55 to -70) could be identi-
ﬁed. ORF48 encodes a putative endolysin with 100% identity to
the endolysin of phage LMA2 and belongs to a lysozyme-like
superfamily.
Bioﬁlm growth by lux-tagged Pseudomonas on CFBE41o-
cell monolayer. We studied the ability of phage to penetrate and
attack Pseudomonas cells growing as bioﬁlms on the surface of a
layer of human lung epithelial cells. CFBE41o- cells (CFBE stands
for cystic ﬁbrosis bronchial epithelial) were grown in standard
6-well tissue culture plates, and a conﬂuent culture with a tight
junction between cells was achieved after 8 to 10 days of incuba-
tion (12). The conﬂuent culture was inoculated with lux-tagged
Pseudomonas strains NH57388A::p16Slux or MR299::p16Slux,
and growth was monitored in this static system for 24 h (Fig. 3A).
Theadditionofarginineintheminimalessentialmedium(MEM)
enhanced the formation of bioﬁlms and helped preserve the in-
tegrityoftheCFBE41o-cells,assuggestedbyAndersonetal.(12).
The amount of luminescence recorded for the growing bioﬁlms
increased by 2 log units during the 24-h incubation (Fig. 3B).
WashingthebioﬁlmmonolayerculturetwicewithMEMremoved
all planktonic Pseudomonas cells. The absence of motile cells and
the presence of only adhered clusters of microcolonies of various
sizesscatteredacrosstheepithelialcellmonolayerwereconﬁrmed
by phase-contrast microscopy (see Fig. S2 in the supplemental
material).Theamountofbioluminescencerecordedafterremov-
ingplanktoniccellswasonly25%lowerthanthatobtainedbefore
washing (Fig. 3A), which conﬁrmed that the majority of Pseu-
domonas cells were adhered to the epithelial monolayer. We de-
termined the number of CFU after washing the monolayer at 2.6
 107 to 3.8  107 CFU/well and 4.2 to 5.4  107 CFU/ well (well
area of 9.5 cm2) for strains NH57388A and MR299, respectively.
Calcoﬂuor white, a ﬂuorescence enhancer that binds to the
(1–3) and (1–4) polysaccharide linkages found in bioﬁlm ma-
trices produced by exopolysaccharide-producing organisms (12,
34, 35) was used to stain bioﬁlms. The staining revealed that the
Pseudomonas cells were contained within a polysaccharide matrix
(Fig. 4A and B). The structures formed by the two Pseudomonas
strains NH57388A and MR299 measured on average 20 to 30
mb y3 0t o4 0m in diameter. The presence of abundant num-
bers of Pseudomonas cells packed in polysaccharide matrices and
attached to the cell line led us to conclude that the microcolony
structures formed on the monolayer ﬁt the deﬁnition of bioﬁlms.
Clearingofbioﬁlmsbyphage.Weexaminedtheabilityofthe
mixture of phages to clear 24-h-old bioﬁlms of P. aeruginosa
NH57388A or MR299. Calcoﬂuor white staining revealed a
change to open and weak matrices in the presence of the NH-4
andMR299-2phages,indicatingconsiderabledestructiontothe
bioﬁlm structure (Fig. 4C and D). At the same time, phage titers
increased almost 2 log units during the 24-h period, conﬁrming
signiﬁcant phage replication (Fig. 4E). The amount of lumines-
cencerecordedforbothPseudomonasbioﬁlmsalsodecreasedby2
log units over a 24-h period (Fig. 5). In contrast, the light level
remained high and unchanged in the control bioﬁlms (with no
phage added) over the same period. Direct plating results also
conﬁrmthatthesigniﬁcantreductioninlightwasadirectresultof
the destruction of the Pseudomonas cells by the phage. The num-
bers of CFU estimated for the bioﬁlms before phage added were
2.6  107 to 3.8  107 CFU/well and 4.2  107 to 5.4  107 CFU/
well (well area of 9.5 cm2) for strains NH57388A and MR299,
respectively, and the amount of phage added was 0.5  108 to 1.0
 108/well (multiplicity of infection [MOI] of 2 to 5). During the
24-h incubation, the number of Pseudomonas cells in the bioﬁlms
was reduced by 3 to 4 log units in the presence of phage.
Clearing of Pseudomonas from murine lungs. The ability of
phage to kill Pseudomonas in situ in the lungs of infected 8-week-
old female BALB/c mice (n  16) was also examined (Fig. 6). In
this regard, lux tagging of Pseudomonas cells was very useful in
monitoringthefateofthesecellsinthelungsofinfectedmice.The
presenceofPseudomonaswasevidentinthelungsofbothtestand
control mice 2 h after infection. The amount of light recorded in
thecontrolmice(withoutphage)increased3-foldandreachedits
maximum level after 6 h. The amount of light recorded in mice
treatedwithphagedecreasedsigniﬁcantlyduringthesameperiod.
DISCUSSION
There has been increased interest in phage therapy as a means of
combatingbacteriallunginfections.However,thereislittleinfor-
mation about the efﬁcacy of bacteriophage in clearing Pseudomo-
nas growing on CF lung tissue or in an animal model. It has been
well documented that the CF lung environment causes normally
FIG 3 (A) Growth of lux-tagged Pseudomonas bioﬁlms on the surface of the
CFBE410-cellmonolayer.Lightwasmeasured1,5,and24h(beforeandafter
the monolayer was washed with MEM). (B) Readings from 6 wells are shown.
Values are shown as means  standard deviations (SD) (error bars).
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38). Our data show that 1 h after the addition of lux-tagged Pseu-
domonascellstoaCFepithelialmonolayer,onlyaverylowlevelof
localized light was detected. The signal then increased over 100-
fold in 24 h (Fig. 3). Washing the 24-h-old bioﬁlm with MEM
medium resulted in 25% reduction in the amount of light, indi-
cating that 75% (2.6  107 to 5.4  107 CFU/well) of the Pseu-
domonas adhered as microcolonies over the entire surface of the
CF cell monolayer. It is well documented in the literature that
microcolonydispersalinPseudomonasisafeatureofbioﬁlmmat-
uration (39–42).
To be effective, phage must be able to penetrate the bioﬁlm
exopolysaccharide.Thismayaccountforthefactthatittookmore
time(22to24h)forphage(atsimilarMOI)toclearPseudomonas
growing on CFBE41o- cells than the 5 to 6 h required to clear
recently introduced planktonic cells from the lungs of infected
mice.WeobservedproliferationofPseudomonascellsinthelungs
of mice in the absence of phage, whereas phage treatment pre-
FIG4 Fluorescentimageof24-h-oldcultureofP.aeruginosacellsgrownonaCFBE41o-cellmonolayerafterCalcoﬂuorwhite(ﬂuorescentenhancer)staining.
Staining conﬁrms that P. aeruginosa NH57388A (A) and MR299 (B) are embedded in an exopolysaccharide structure prior to phage exposure. After 24-h
incubation in the presence of mixed phages, staining indicates open and weak matrices with reduced numbers of cells for both NH57388A (C) and MR299 (D).
An increase in phage titer was observed over the 24-h incubation period for both MR299 and NH57388A strains (E).
FIG 5 (A) Light emitted from nonmucoid P. aeruginosa MR299 strain and mucoid NH57388A strain grown on a CFBE410- cell monolayer for 24 h in the
presence () and absence () of phage mix. (B) The RLU values are mean  SD readings from 3 wells.
Phage for Pseudomonas aeruginosa
March/April 2012 Volume 3 Issue 2 e00029-12
® mbio.asm.org 5vented growth and reduced the bacterial load to a nondetectable
level during the 6-h period. A recent study reported that the
amountoflightmeasuredinmiceinfectedwithalux-taggedPseu-
domonas PAK strain also decreased over 6 h when phage PAK-P1
was administered 2 h after infection (24, 25). The amount of light
increased in the control mice and in the mice that received a de-
layedphagetreatment.Theauthorsconcludedthatadministering
phage 2 h after infection was critical to resolving infection in the
mouse model system and suggested that the efﬁcacy of phage
needed to be tested against bioﬁlms.
One advantage of using phage to control bacterial infection is
that they can replicate at the infection site (24). In addition to
being a very effective way of clearing Pseudomonas, the use of a
phage mix has another advantage over the use of a single phage in
that it reduces the likelihood of a phage resistance population
emerging. Different phages often use different bacterial receptors
and therefore will require independent mutations to generate re-
sistance to each phage (43). Consequently, unless mutants with
generalized resistance mechanism evolve, a mix of different
phages for which there is no cross-resistance should be able to
prevent multiple phage resistance and provide indeﬁnite control
of bacterial population.
In conclusion, this study demonstrates that Pseudomonas
growingonaCFairwaytissuemonolayercouldbekilledbyphage.
Since chronic lung infections in CF patients are associated with
Pseudomonas bioﬁlms rather than planktonic cells, we anticipate
that bioﬁlm clearing from lungs of CF patients by bacteriophage
might take place in a similar manner to that observed with the
exopolysaccharide-producing microcolonies growing on an epi-
thelial cell monolayer. Moreover, we subsequently demonstrate
thatthesamephagemixwaseffectiveinkillingthepathogeninthe
lungs of infected mice. Our study reinforces the growing interest
inusingphagetherapyasameansofattackingmultidrug-resistant
CF infections.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Pseudomonas strains isolated
fromCFpatientsandusedinthisstudyareshowninTable1.LBmedium
wasusedthroughoutthisstudytoculturePseudomonasstrains.Adouble-
strengthLBmediumwasmadeforphageisolationbydoublingtheweight
of dry ingredients required to prepare single-strength LB broth. Cultures
were grown at 37°C under aerobic conditions and shaking at 180 rpm.
Solid media and soft agar overlays contained 1.5% and 0.7% agar (BD
Difco, Oxford, United Kingdom), respectively.
TransformationofPseudomonaswithp16luxplasmid.P.aeruginosa
strainsNH57388A(mucoid)andMR299(nonmucoid)weretransformed
with p16Slux plasmid (44) by the method of Shen et al. (45). In brief,
Pseudomonas strains were grown in LB medium at 37°C until an optical
density (OD) at 600 nm of 0.8 is reached. To facilitate electroporation,
Pseudomonas exopolysaccharide was digested by adding alginate-lyase
(catalog no. A1603; Sigma, Japan) to a ﬁnal concentration of2Um l 1.
Thecellenzymemixturewasincubatedat37°Cfor30min.Thecellswere
centrifuged at 10,000  g (4°C) for 10 min. The resultant pellet was
washed twice with chilled electroporation buffer (containing 300 mM
glucose,5mmCaCl2,and25mMHEPESindistilledwater[pH7.0])and
resuspended in 0.1 ml of buffer (1  109 to 1  1010 CFU/ml). These
electrocompetent cells were mixed with 10 l of p16Slux-tagged plasmid
DNA (10 g) and incubated on ice for 10 to 15 min. The mixture was
immediatelytransferredtoachilledelectroporationcuvette(0.2-cmelec-
trodegapGene-pulsercuvette;Bio-Rad,Hercules,CA)andsubjectedtoa
FIG6 Mice (n  8) were infected with nonmucoid P. aeruginosa MR299 (A) and mucoid NH57388A (mucoid strain) (B). Test mice () were treated with the
phage mix (MR299-2 and NH-4B). Phage was given 2 h after the mice were infected with Pseudomonas. Control mice () did not receive the phage mix.
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precision pulse apparatus (Holliston, MA) at the following settings: ca-
pacitor, 25 F; resistor, 200 ; and voltage, 2.5 kV. Immediately after the
electric shock, 900 l of chilled SOC medium (catalog no. S1797; Sigma-
Aldrich) was added to the mixture and incubated on ice for 10 min, fol-
lowed by incubation at 30°C for 2 to 3 h. The cells were concentrated by
centrifugationat10,000g(roomtemperature),andtransformantswere
obtainedbyplatingcellsonLBagarcontainingerythromycin(800g/ml)
and incubating at a permissive temperature (30°C) for 24 to 48 h. Eryr
colonies were checked for light emission using a VivoVision IVIS100 im-
aging system (Xenogen, Alameda, CA), luminescence was measured in
relative light units (RLU) (in photons second1), and the presence of
p16Slux was conﬁrmed by miniprep and restriction analyses. A standard
curvewasgeneratedtodeterminetherelationshipbetweenlightmeasure-
ments and CFU (see Fig. S3 and Table S2 in the supplemental material).
Isolation of phage from sewage. Pseudomonas phages were isolated
from fresh sewage obtained from a local sewage treatment plant as de-
scribed previously (46) with some modiﬁcations. Sewage samples were
centrifugedat3,200gvalue(HeraeusLabofuge400centrifuge;Thermo
Fisher Scientiﬁc, Inc., MA) for 12 min, and the supernatant was ﬁltered
using a 0.45-m-pore-size ﬁlter (Sarstedt, Actiengeselischaft and Co.,
Germany). The sewage ﬁltrate (5 ml) was mixed with an equal volume of
double-strength LB broth, supplemented with 10 mM CaCl2, and inocu-
latedwithamixtureoftenCFP.aeruginosacultures(50leachof1107
to2107/ml).Thesampleswereincubatedovernightaerobically(37°C)
with slow shaking (20 to 30 rpm). Following overnight incubation, the
cultureswerecentrifugedat3,200gvaluefor12mintoremovebacterial
cells and debris, and the supernatant was ﬁltered through a sterile 0.45-
m-pore-size ﬁlter. A double-layer LB agar plate containing a lawn of
individual host culture supplemented with 10 mM CaCl2 was prepared,
and 10 l of cell-free ﬁltrate containing phage was applied to the plate.
The plates were examined for the presence of plaques after incubating
aerobically for 18 to 24 h at 37°C.
Plaque puriﬁcation and bacteriophage titers. Phages were puriﬁed
by successive single plaque isolation and propagation. In general, a single
plaque was picked from a plate using a sterile capillary tube and added to
a mid-log-phase Pseudomonas culture (108 CFU/ml) supplemented with
10 mM CaCl2. The culture mixture and phage mixture were incubated at
37°Covernight.Thelysatewasﬁlteredthrougha0.45-m-pore-sizester-
ile ﬁlter, serial dilutions were made, and plaques were allowed to form on
a lawn of the same host culture. Single plaques were puriﬁed through 3
successive rounds of plaquing and repeated three additional times after
which puriﬁed phages were obtained. Phage titer was determined as the
number of PFU/ml by plaque assay as previously described (47).
DNA extraction and restriction digestion analysis. High-titer-
puriﬁed phage suspension was prepared by concentration of phage parti-
cles from 400 ml cell lysate in LB medium to a ﬁnal volume of 1 ml in
sterile ice-cold ammonium acetate (0.1 M, pH 7.2) as described before
(46), and DNA was extracted from the high-titer-puriﬁed phage as previ-
ously described (46, 48, 49). Phage DNA was digested with restriction
endonucleaseEcoRI(NewEnglandBiolabs,MA)accordingtothesuppli-
er’s recommendation, and digested samples were analyzed by gel electro-
phoresis using agarose gel (0.7%) containing ethidium bromide (SF1).
Genomesequencingandannotation.ThegenomesofphagesNH-4
and 299-2 were sequenced by Beckman Coulter Genomics (Sanger se-
quencingservices;BeckmanCoulter,Takeley,UnitedKingdom)ona454
GS-FLX sequencer, and sequences were assembled into contigs using the
Newbler program (Roche Applied Sciences). The quality of the sequence
was assessed using Hawkeye (Amos) (50). To conﬁrm phage genome
structure, primers were designed at contig ends for PCR ampliﬁcation
using Platinum PCR SuperMix (Invitrogen) followed by direct sequenc-
ing of the PCR products, and full phage genome assembly was performed
using the Phred-Phrap-Consed package (51, 52). ORFs were predicted
using GLIMMER 3.02 (53). The resulting gene models were fed into GA-
MOLA (54) for annotation. Complementary annotation was provided
usingtheRASTannotationserver(55).Dataweremanuallycuratedusing
Artemis version 11 (56) where additional programs were then used, in-
cluding BLASTp (57), GATU (58) and RBS ﬁnder (53). Comparative
genomics with reference phages (PaP3 and LMA2) were analyzed us-
ingtheArtemiscomparisontool(ACT)(7)andtheMauvealignmenttool
(59).
Electron microscopy and phage characterization. Electron micros-
copyimageofphageswasobtainedbyapplyingadropofhigh-titerphage
suspension (1  109 to 2  109 PFU/ml) deposited on carbon-coated
copper grids, negatively stained with 2% (wt/vol) potassium phospho-
tungstate (pH 7.2) and examined with Zeiss Supra 40VP scanning elec-
tron microscope (Carl Zeiss SMT Ltd., Cambridge, United Kingdom)
ﬁttedwithascanningtransmissionelectronmicroscopedetector(STEM)
operating in bright-ﬁeld mode at an accelerating voltage of 25 kV
(Moorepark National Food Imaging Centre, TEAGASC Food Research
Centre [TFRC], and Advanced Microscope Research Facility, University
College Cork, Cork, Ireland).
CellcultureandPseudomonasbioﬁlmformationonthesurfaceofa
monolayerofhumanbronchialepithelialcells(CFBE41o-cells).Cystic
ﬁbrosisbronchialepithelial(CFBE41o-)cell(60,61)culturesweregrown
by the method of Anderson et al. (12). In general, CFBE41o- cells were
seeded in sterile 6-well, ﬂat-bottom tissue culture plates (Sarstedt, New-
ton, NC) at a concentration of 106 cells/well and maintained in minimal
essential medium (MEM) containing 10% fetal bovine serum, 2 mM
l-glutamate, 100 g/ml penicillin, and 100 g/ml streptomycin (all from
Invitrogen GIBCO, United Kingdom). The cells were grown at 37°C and
5% CO2 using a Jouan IGO150 cell life incubator (Jouan, St. Herblain,
France) for 8 to 10 days until cells form a conﬂuent monolayer and tight
junctions. The medium (MEM) was changed every 2 or 3 days until con-
ﬂuent growth was achieved.
For bioﬁlm formation, lux-tagged P. aeruginosa cells were grown on
the conﬂuent CFBE41o- cell monolayer using a coculture model system
(12). Once the monolayer growth was achieved (between 8 and 10 days),
the medium was replaced with 1.5 ml fresh MEM (without fetal bovine
serum, penicillin, and streptomycin), and lux-tagged Pseudomonas cells
wereinoculated(1107to2107CFU/well).Theplateswereincubated
at 37°C and 5% CO2 for 1 h. The medium containing the unattached
(planktonic) Pseudomonas cells was then removed using a sterile serolog-
ical pipette and replaced with fresh MEM supplemented with 0.4% argi-
nineandincubatedfor24h.PlanktonicPseudomonascellswereremoved,
andthebioﬁlmculturewaswashedtwiceusingMEMsupplementedwith
0.4%arginine.Theintegrityoftheepithelialcellmonolayerandthepres-
ence of growing Pseudomonas microcolonies were assessed by phase-
contrast microscopy (Olympus IX50 inverted system microscope; Olym-
pus Co., Tokyo, Japan). Luminescence from bioﬁlms was monitored by
Vivo Vision IVIS100 imaging system (Xenogen, Alameda, CA). Bioﬁlm
CFU was estimated by the method of Wirtanen et al. (62) with some
modiﬁcations.A24-hbioﬁlmgrowingonanepithelialcellmonolayerwas
washedtwicewithMEMandthenscrapedoffusingatissueculturescrap-
per and transferred to a 2-ml Eppendorf tube containing 1 ml phosphate
buffer.Thetubewasthenvortexedthoroughlyfor1to2mintoreleasethe
cells. After this, the samples were then serially diluted, and a plate count
was made on a LB plate incubated at 37°C overnight.
Applying phages to bioﬁlms and lung infections in mice. Fifty mi-
croliters of the phage mixture (1  109 to 2  109 PFU/ml of deﬁned
phage [containing NH-4 and MR299-2] in a 1:1 mixture) was applied
towellscontaining24-h-oldbioﬁlmsonaCFBE41o-cellmonolayer,and
the plates were incubated at 37°C and 5% CO2 for 24 h. Bioﬁlm clearing
was monitored by measuring light and images taken for times indicated,
usingtheIVIS100imagingsystem.Thelungsof6-to8-week-oldconven-
tional female BALB/c mice (n  16) were infected with Pseudomonas by
the method of Riedel et al. (28). The mice were infected intranasally with
50 l lux-tagged PseudomonasNH57388A or MR299 in phosphate buffer
(2  108 to 5  108 CFU/ml). Two hours following infection, 50 lo fa
phage mix suspension in phosphate buffer containing Pseudomonas
Phage for Pseudomonas aeruginosa
March/April 2012 Volume 3 Issue 2 e00029-12
® mbio.asm.org 7phages NH-4 and MR299-2 (2  109 to 5  109 PFU/ml for a multi-
plicity of infection [MOI] of 10) were given intranasally. Fifty microliters
of phosphate buffer was given to the control groups. Animals were anes-
thetized with isoﬂurane, light was monitored, and images were taken us-
ingtheIVIS100systematthetimepointsindicated.Animalswerekeptin
ananimalcolony,andallexperimentswereapprovedbytheanimalethics
committee of University College Cork.
Bioﬁlmstaining.Pseudomonasbioﬁlmswerestainedwiththeﬂuores-
cent enhancer Calcoﬂuor white (ﬂuorescent brightener 28, catalog no.
F3543;SigmaAldrich,China).Inbrief,themonolayersofCFBE41o-cells
containing bioﬁlms were removed from wells using a sterile cell scraper
(Sarstedt,ActiengeselischaftandCo.,Germany)andmixedwithadropof
Calcoﬂuorwhite(0.1%)onamicroscopeslide.Acoverslipwasappliedto
the slide; the edges were sealed with parafﬁn oil, and the microscope slide
was incubated for 1 h (37°C). Stained bioﬁlm preparations were assessed
by using an Olympus BX51 ﬂuorescence microscope ﬁtted with a
U-RFL-T ﬂuorescent power supply unit, and images were taken with a
DP50 integrated camera (all from Olympus Optical Co., Japan).
Nucleotide sequence accession numbers. The completed phage ge-
nome sequences of phages NH-4 and MR299-2 were deposited in Gen-
Bank database and assigned accession numbers JN254800 and JN254801,
respectively.
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